RA
NXGN

Royce & Associates’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Royce & Associates’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,903
Closed -$347K – 984
2022
Q2 		$347K Sell
19,903
-25,141
-56% -$479K ﹤0.01% 871
2022
Q1 		$942K Sell
45,044
-6,879
-13% -$132K 0.01% 812
2021
Q4 		$924K Buy
51,923
+8,940
+21% +$144K 0.01% 819
2021
Q3 		$606K Buy
42,983
+14,432
+51% +$224K ﹤0.01% 875
2021
Q2 		$474K Buy
28,551
+6,097
+27% +$109K ﹤0.01% 936
2021
Q1 		$406K Buy
22,454
+304
+1% +$6K ﹤0.01% 964
2020
Q4 		$404K Sell
22,150
-452
-2% -$7.17K ﹤0.01% 913
2020
Q3 		$288K Sell
22,602
-429
-2% -$5.48K ﹤0.01% 904
2020
Q2 		$253K Buy
23,031
+7,127
+45% +$73.8K ﹤0.01% 919
2020
Q1 		$166K Buy
+15,904
New +$205K ﹤0.01% 937
2018
Q4 		– Sell
-1,353
Closed -$27K – 1215
2018
Q3 		$27K Buy
1,353
+318
+31% +$6.74K ﹤0.01% 1124
2018
Q2 		$20K Buy
1,035
+217
+27% +$3.43K ﹤0.01% 1126
2018
Q1 		$11K Sell
818
-35
-4% -$461 ﹤0.01% 1168
2017
Q4 		$12K Buy
853
+183
+27% +$2.63K ﹤0.01% 1154
2017
Q3 		$11K Buy
+670
New +$10.8K ﹤0.01% 1154
2015
Q4 		– Sell
-2,800
Closed -$35K – 1184
2015
Q3 		$35K Hold
2,800
– – ﹤0.01% 1172
2015
Q2 		$46K Buy
+2,800
New +$45.1K ﹤0.01% 1184
2015
Q1 		– Sell
-56,300
Closed -$878K – 1308
2014
Q4 		$878K Hold
56,300
– – ﹤0.01% 1095
2014
Q3 		$775K Sell
56,300
-399,900
-88% -$6.07M ﹤0.01% 1162
2014
Q2 		$7.32M Buy
456,200
+67,200
+17% +$1.06M 0.02% 773
2014
Q1 		$6.57M Buy
389,000
+199,000
+105% +$3.61M 0.02% 807
2013
Q4 		$4M Buy
+190,000
New +$4.28M 0.01% 931

Other funds holding NXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates's NXGN Position: Q3 2022 in Review

Royce & Associates sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2022, closing a stake of 19,903 shares — an estimated $347K sold.

Royce & Associates first reported a position in NXGN in Q4 2013 and held it in 22 quarters. The position peaked at $7.32M in Q2 2014. 187 funds tracked by Wall St. Rank hold NXGN as of Q3 2022.

  • Royce & Associates reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Royce & Associates sold 19,903 NextGen Healthcare, Inc. Common Stock shares in Q3 2022, an estimated $347K.
  • Royce & Associates first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2013 and held it in 22 quarters.
  • Royce & Associates's NextGen Healthcare, Inc. Common Stock position peaked at $7.32M in Q2 2014.
  • 187 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2022.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.